ESR1 and invasive breast carcinoma: TNBC is a subtype of BrCa in which estrogen receptor (ER), progesterone receptor, and HER2 are not expressed; ~ 15–20% of BrCa cases are TNBC (Foulkes et al., 2010; Goldhirsch et al., 2011).